Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management

Immune checkpoint inhibitors (ICIs), as one of the innovative types of immunotherapies, including programmed cell death-1 (PD-1), programmed cell death-ligand 1 (PD-L1), and cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibitors, have obtained unprecedented benefit in multiple malignancies. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Liansha, Wang, Jialing, Lin, Nan, Zhou, Yuwen, He, Wenbo, Liu, Jiyan, Ma, Xuelei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724248/
https://www.ncbi.nlm.nih.gov/pubmed/34992611
http://dx.doi.org/10.3389/fimmu.2021.800879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724248/
https://www.ncbi.nlm.nih.gov/pubmed/34992611
http://dx.doi.org/10.3389/fimmu.2021.800879

Ejemplares similares